Disease-specific overall survival in endometrioid ovarian

Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions

PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair

Mode of Referral of Ovarian Cancer Patients: Does it Alter Treatment and Survival?

Endometriosis in clear cell and endometrioid carcinoma ovary: its impact on clinicopathological characteristics and survival outcomes - ecancer

Uterine Cancer (Endometrial Cancer): Symptoms & Treatment

Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway - Fortner - 2023 - International Journal of Cancer - Wiley Online Library

Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data

Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma

Pretreatment with LCK Inhibitors Chemosensitizes Cisplatin-Resistant Endometrioid Ovarian Tumors

Diagnostics, Free Full-Text

Genomic subtypes of endometrioid ovarian carcinoma demonstrate distinct

Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment - Gynecologic Oncology

Frontiers Risk Factors and Prognosis of Early Recurrence in Stage I–II Endometrial Cancer: A Large-Scale, Multi-Center, and Retrospective Study

Synchronous endometrial and ovarian cancer: A case report

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome